Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method.
Recombinant adeno-associated virus (rAAV) vectors offer promise for gene therapy of alpha-1 antitrypsin (AAT) deficiency. A toxicology study in mice evaluated intramuscular injection of an rAAV vector expressing human AAT (rAAV-CB-hAAT) produced using a herpes simplex virus (HSV) complementation system or a plasmid transfection (TFX) method at doses of 3 × 10(11) vg (1.2 × 10(13) vg/kg) for both vectors and 2 × 10(12) vg (8 × 10(13) vg/kg) for the HSV-produced vector. The HSV-produced vector had favorable in vitro characteristics in terms of purity, efficiency of transduction, and hAAT expression. There were no significant differences in clinical findings or hematology and clinical chemistry values between test article and control groups and no gross pathology findings. Histopathological examination demonstrated minimal to mild changes in skeletal muscle at the injection site, consisting of focal chronic interstitial inflammation and muscle degeneration, regeneration, and vacuolization, in vector-injected animals. At the 3 × 10(11) vg dose, serum hAAT levels were higher with the HSV-produced vector than with the TFX-produced vector. With the higher dose of HSV-produced vector, the increase in serum hAAT levels was dose-proportional in females and greater than dose-proportional in males. Vector copy numbers in blood were highest 24 hr after dosing and declined thereafter, with no detectable copies present 90 days after dosing. Antibodies to hAAT were detected in almost all vector-treated animals, and antibodies to HSV were detected in most animals that received the highest vector dose. These results support continued development of rAAV-CB-hAAT for treatment of AAT deficiency.
Chulay
Jeffrey D
JD
Applied Genetic Technologies Corporation, 11801 Research Drive, Alachua, FL 32615, USA. jchulay@agtc.com
Ye
Guo-Jie
GJ
Thomas
Darby L
DL
Knop
David R
DR
Benson
Janet M
JM
Hutt
Julie A
JA
Wang
Gensheng
G
Humphries
Margaret
M
Flotte
Terence R
TR
D000704:Analysis of Variance; D000818:Animals; D002478:Cells, Cultured; D000229:Dependovirus / Q000235:genetics*; D004353:Drug Evaluation, Preclinical; D005260:Female; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000097:blood / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D018139:Simplexvirus / Q000235:genetics*; D014162:Transfection; D000515:alpha 1-Antitrypsin / Q000235:genetics*; D019896:alpha 1-Antitrypsin Deficiency / Q000628:therapy*
D000515:alpha 1-Antitrypsin
J Virol. 1999 May;73(5):3994-4003
10196295
Gene Ther. 2004 Jul;11(13):1081-6
15057263
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8
19706466
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11854-9
12192090
Gene Ther. 2001 Sep;8(17):1299-306
11571566
Percept Psychophys. 2001 Nov;63(8):1399-420
11800465
Bioinformatics. 2003 May 22;19(8):966-72
12761059
Gene Ther. 2009 Feb;16(2):229-39
18923452
Blood. 2003 Jul 15;102(2):480-8
12637328
Hum Gene Ther. 1998 Dec 10;9(18):2745-60
9874273
N Engl J Med. 2002 Nov 21;347(21):1652-61
12444179
Mol Ther. 2009 Jan;17(1):81-7
18941444
J Gene Med. 2006 Jun;8(6):730-5
16518879
J Gene Med. 2005 Jul;7(7):842-50
15838934
Blood. 2003 Apr 15;101(8):2963-72
12515715
Chest. 1991 Sep;100(3):703-8
1889260
J Virol. 2003 Feb;77(4):2768-74
12552020
JAMA. 2006 Aug 23;296(8):964-73
16926356
JAMA. 1999 Jul 28;282(4):331-40
10432030
J Virol. 2002 Jan;76(2):791-801
11752169
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14384-8
9826709
N Engl J Med. 2009 Jun 25;360(26):2749-57
19553648
Chest. 1989 Jan;95(1):196-208
2642408
Hum Gene Ther. 2007 Mar;18(3):245-56
17376008
Clin Infect Dis. 2005 May 1;40(9):1271-81
15825029
Hum Gene Ther. 2006 Dec;17(12):1177-86
17115945
Mol Ther. 2001 Sep;4(3):217-22
11545612
Nat Med. 2006 Mar;12(3):342-7
16474400
Hum Gene Ther. 2009 Aug;20(8):861-70
19419276